Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
948,058
-
Share change
-
+126,290
-
Total reported value
-
$7,090,956
-
Price per share
-
$7.48
-
Number of holders
-
27
-
Value change
-
+$882,833
-
Number of buys
-
14
-
Number of sells
-
8
Institutional Holders of OPIANT PHARMACEUTICALS INC - COM (OPNT) as of Q3 2020
As of 30 Sep 2020,
OPIANT PHARMACEUTICALS INC - COM (OPNT) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
948,058 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, WELLS FARGO & COMPANY/MN, Fondren Management LP, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, NORTHERN TRUST CORP, PERRITT CAPITAL MANAGEMENT INC, BlackRock Inc., GSA CAPITAL PARTNERS LLP, and DIMENSIONAL FUND ADVISORS LP.
This page lists
27
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.